GAM Holding’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-44,265
| Closed | -$861K | – | 1021 |
|
|
2018
Q1 | $861K | Sell |
44,265
-33,266
| -43% | -$653K | 0.03% | 495 |
|
|
2017
Q4 | $1.29M | Buy |
+77,531
| New | +$1.42M | 0.04% | 504 |
|
|
2016
Q1 | – | Sell |
-41,000
| Closed | -$1.75M | – | 1116 |
|
|
2015
Q4 | $1.75M | Hold |
41,000
| – | – | 0.03% | 535 |
|
|
2015
Q3 | $1.44M | Hold |
41,000
| – | – | 0.02% | 588 |
|
|
2015
Q2 | $1.88M | Sell |
41,000
-6,000
| -13% | -$285K | 0.03% | 547 |
|
|
2015
Q1 | $2.2M | Buy |
47,000
+3,500
| +8% | +$139K | 0.03% | 493 |
|
|
2014
Q4 | $1.38M | Buy |
43,500
+1,900
| +5% | +$55.6K | 0.02% | 616 |
|
|
2014
Q3 | $986K | Hold |
41,600
| – | – | 0.01% | 714 |
|
|
2014
Q2 | $1.25M | Hold |
41,600
| – | – | 0.02% | 657 |
|
|
2014
Q1 | $1.1M | Buy |
+41,600
| New | +$1.04M | 0.02% | 661 |
|
|
2013
Q4 | – | Sell |
-41,600
| Closed | -$853K | – | 1089 |
|
|
2013
Q3 | $853K | Buy |
+41,600
| New | +$859K | 0.02% | 697 |
|
GAM Holding's IPXL Position: Q2 2018 in Review
GAM Holding sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 44,265 shares — an estimated $861K sold.
GAM Holding first reported a position in IPXL in Q3 2013 and held it in 11 quarters. The position peaked at $2.2M in Q1 2015. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- GAM Holding reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- GAM Holding sold 44,265 Impax Laboratories, Inc. shares in Q2 2018, an estimated $861K.
- GAM Holding first reported a position in Impax Laboratories, Inc. in Q3 2013 and held it in 11 quarters.
- GAM Holding's Impax Laboratories, Inc. position peaked at $2.2M in Q1 2015.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on GAM Holding's 13F filing for Q2 2018, filed 9 Aug 2018.